We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Express Scripts Takes Swipe at Valeant Over Glumetza Cost
Express Scripts Takes Swipe at Valeant Over Glumetza Cost
The war on high pharmaceutical prices continues, with PBM Express Scripts taking aim at what it calls an excessive price jump for Valeant Pharmaceuticals’ diabetes drug Glumetza.